HARVARD BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
HARVARD BIOSCIENCE, INC. (HBIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 3.70% for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2025-11-06
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2017-09-30 was 1.74%, a 72.28% increase year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2017-06-30 was 1.92%, a 37.14% increase year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2017-03-31 was 1.89%, a 27.70% increase year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2016-09-30 was 1.01%, a 42.61% decline year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2017 was 2.03%, a 57.36% increase from fiscal 2016.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2016 was 1.29%, a 25.00% decline from fiscal 2015.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2015 was 1.72%, a 4.44% decline from fiscal 2014.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2014 was 1.80%, a 26.76% increase from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|
| 2025-09-30 | 3.70% 10-Q · filed 2025-11-06 | |||
| 2017-12-31 | 2.03% 10-K · filed 2018-03-16 | |||
| 2017-09-30 | 1.74% 10-Q · filed 2017-11-02 | 1.88% 10-Q · filed 2017-11-02 | ||
| 2017-06-30 | 1.92% 10-Q · filed 2017-08-03 | 1.99% 10-Q · filed 2017-08-03 | ||
| 2017-03-31 | 1.89% 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | 1.29% 10-K · filed 2018-03-16 | |||
| 2016-09-30 | 1.01% 10-Q · filed 2017-11-02 | 1.29% 10-Q · filed 2017-11-02 | ||
| 2016-06-30 | 1.40% 10-Q · filed 2017-08-03 | 1.45% 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | 1.48% 10-Q · filed 2017-05-08 | |||
| 2015-12-31 | 1.72% 10-K · filed 2018-03-16 | |||
| 2015-09-30 | 1.76% 10-Q · filed 2016-11-03 | 1.72% 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | 1.70% 10-Q · filed 2016-08-04 | 1.72% 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | 1.74% 10-Q · filed 2016-05-16 | |||
| 2014-12-31 | 1.80% 10-K · filed 2017-03-17 | |||
| 2014-09-30 | 1.90% 10-Q · filed 2015-11-05 | 1.79% 10-Q · filed 2015-11-05 | ||
| 2014-06-30 | 1.80% 10-Q · filed 2015-08-06 | 1.78% 10-Q · filed 2015-08-06 | ||
| 2014-03-31 | 1.22% 10-Q · filed 2015-05-07 | |||
| 2013-12-31 | 1.42% 10-K · filed 2016-04-29 | |||
| 2013-09-30 | 0.00% 10-Q · filed 2014-11-06 | 1.18% 10-Q · filed 2014-11-06 | ||
| 2013-06-30 | 1.18% 10-Q · filed 2014-08-07 | 1.18% 10-Q · filed 2014-08-07 | ||
| 2012-12-31 | 0.80% 10-K · filed 2015-03-12 | |||
| 2012-09-30 | 0.80% 10-Q · filed 2013-11-08 | |||
| 2012-06-30 | 0.78% 10-Q · filed 2013-08-09 | 0.80% 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | 1.17% 10-Q · filed 2013-05-10 | |||
| 2011-12-31 | 2.01% 10-K · filed 2014-03-14 | |||
| 2011-09-30 | 2.01% 10-Q · filed 2012-11-08 | |||
| 2011-06-30 | 2.01% 10-Q · filed 2012-08-09 | 2.01% 10-Q · filed 2012-08-09 | ||
| 2010-12-31 | 2.22% 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |